AmoyDx BRCA1/2 Mutation Detection Kit
Prostate Cancer / Ovarian Cancer
CommercialApproved as CDx for AKEEGA (niraparib/abiraterone) in China
Key Facts
Indication
Prostate Cancer / Ovarian Cancer
Phase
Commercial
Status
Approved as CDx for AKEEGA (niraparib/abiraterone) in China
Company
About Amoy Diagnostics
A precision oncology diagnostics company developing PCR and NGS-based companion diagnostic kits for cancer, with a focus on accessibility and global partnerships.
View full company profile